Moody's Forecasts More Gloom & Doom for Pharma Industry

Nov. 18, 2010

Add Us On Google

Related

Charles River reports lower Q4 2025 revenue in struggling CDMO business

Charles River reports lower Q4 2025 revenue in struggling CDMO business

UK pharmaceuticals exempt from tariffs in US drug pricing agreement

UK pharmaceuticals exempt from tariffs in US drug pricing agreement

2026 Manufacturing Pharma Trends for Life Sciences

Sponsored

2026 Manufacturing Pharma Trends for Life Sciences

2026 AI Trends in Life Sciences

Sponsored

2026 AI Trends in Life Sciences

Trending

Thermo Fisher continues to invest in pharma services capabilities in 2026

AGC Biologics to expand CDMO capabilities in Japan with new $350M Yokohama site

Trump’s FY27 budget proposes $325M increase for domestic pharma manufacturing

Sponsored Picks

Sponsored

Condensate Management in Your Compressed Air System

Sponsored

The Battle in Your Pipes: Gravity vs Air Velocity in Condensate Mgmt

Sponsored

An Advanced Way to Install a Compressed Air System